Study points to novel method for early diagnosis of cachexia in lung cancer patients

by Ricardo Muniz,FAPESPCachexia classification models.ADecision tree generated using Classification And Regression Trees (CART). The bottom boxes indicate hazard ratios, the number o

Updated on: January 08,2024

Study points to novel method for early diagnosis of cachexia in lung cancer patients

by Ricardo Muniz,FAPESPCachexia classification models.ADecision tree generated using Classification And Regression Trees (CART). The bottom boxes indicate hazard ratios, the number o

Updated on:January 08,2024

Findings of large clinical trial may have major implications for treatment of small-cell lung cancer

by SUNY Upstate Medical UniversityCredit: Pixabay/CC0 Public DomainA clinical trial led by Upstate Medical University radiation oncologist Dr. Jeffrey Bogart may have major implications for the treatm

Updated on: December 20,2023

Findings of large clinical trial may have major implications for treatment of small-cell lung cancer

by SUNY Upstate Medical UniversityCredit: Pixabay/CC0 Public DomainA clinical trial led by Upstate Medical University radiation oncologist Dr. Jeffrey Bogart may have major implications for the treatm

Updated on:December 20,2023

Scientists identify gene target to boost effectiveness of cancer immunotherapy

by Katie Marquedant,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainImmune checkpoint inhibitors are important medications that boost the immune system's response against vari

Updated on: December 27,2023

Scientists identify gene target to boost effectiveness of cancer immunotherapy

by Katie Marquedant,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainImmune checkpoint inhibitors are important medications that boost the immune system's response against vari

Updated on:December 27,2023

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye

Updated on: October 24,2023

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye

Updated on:October 24,2023

Sleep disturbances are underappreciated in prostate cancer survivorship

by Tim Baker, Prostate Cancer Foundation of AustraliaCredit: CC0 Public DomainWe all got the memo that sleep is foundational for good health, right?Yet, it remains easy to overlook the importance of&n

Updated on: January 04,2024

Sleep disturbances are underappreciated in prostate cancer survivorship

by Tim Baker, Prostate Cancer Foundation of AustraliaCredit: CC0 Public DomainWe all got the memo that sleep is foundational for good health, right?Yet, it remains easy to overlook the importance of&n

Updated on:January 04,2024

Financial impacts of cancer found to intensify disease burden among German patients

byEuropean Society for Medical OncologyA study conducted in Germany draws attention to the fact that the socio-economic burden of cancer is real in Europe too, and not only in the context of the

Updated on: December 18,2023

Financial impacts of cancer found to intensify disease burden among German patients

byEuropean Society for Medical OncologyA study conducted in Germany draws attention to the fact that the socio-economic burden of cancer is real in Europe too, and not only in the context of the

Updated on:December 18,2023

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024

Scientists reveal a potential new approach to treating liver cancer

byNational Institutes of Healtha, Schematic of drug screening and validation studies; MoA, mechanism of action.b, Graphs of the results from the small-molecule screen with the MIPE library

Updated on: December 27,2023

Scientists reveal a potential new approach to treating liver cancer

byNational Institutes of Healtha, Schematic of drug screening and validation studies; MoA, mechanism of action.b, Graphs of the results from the small-molecule screen with the MIPE library

Updated on:December 27,2023

Investigating quality of life in those with large B-cell lymphoma

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainPatient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that tho

Updated on: December 20,2023

Investigating quality of life in those with large B-cell lymphoma

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainPatient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that tho

Updated on:December 20,2023

American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainA newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on

Updated on: December 28,2023

American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainA newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on

Updated on:December 28,2023

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun

Updated on: December 19,2023

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun

Updated on:December 19,2023

Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer

byBrigham and Women's HospitalScientists developed a bifunctional therapeutic strategy by transforming living tumor cells into a therapeutic. Shah’s team engineered living tumor cells using

Updated on: December 27,2023

Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer

byBrigham and Women's HospitalScientists developed a bifunctional therapeutic strategy by transforming living tumor cells into a therapeutic. Shah’s team engineered living tumor cells using

Updated on:December 27,2023